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Delay in diagnosis of Toxoplasma gondii infection in pregnant women who have been infected during 
the first trimester of gestation can lead to death of her fetus. Serological tests based on recombinant 
proteins are the main diagnosis methods for the detection of anti Toxoplasma antibody in serum 
samples. The aim of this study was to clone and express a gene encoding a P22 protein of T. gondii 
tachyzoite as using antigen for ELISA serology method. DNA was extracted from T. gondii (RH-strain) 
tachyzoites and PCR reaction was done using corresponding primers. The PCR product was purified, 
ligated to PTZ57R plasmid via T/A cloning method and subcloned into SacI and BamHI digested pET32a 
expression vector. Recombinant plasmid was transformed in E. coli (Bl21 DE3) and induced by 1 mM 
IPTG and analyzed by 12% SDS-PAGE. Expressd protein was purified by affinity chromatography and 
confirmed by western blot analysis. We successfully cloned and expressed T. gondii P22 protein. 
 





Toxoplasma gondii is an obligatory protozoan parasite 
with a complicated life cycle. Sexual reproduction of this 
parasite develops in intestine of felines while asexual 
reproduction occurs in the tissue of mammals and birds 
(Frankel et al., 1970). 
The main transmission routes of T. gondii is by inges-
tion of oocyst via contaminated foods, poorly cooked or 
raw meat of livestock and birds or via intrauterine 
transmission (Miller et al., 1972). It is important to 
mention that immunocompromised patients and pregnant 
women who become infected during gestation are the 
two important groups for developing an acute and severe 
disease (Guerina, 1994; Luft and Remington, 1992; 
Cohen, 1970). The later can lead to congenital toxoplas-
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It should be mentioned that  the  severity  of  the  disease 
depends on the duration of acquired infection in pregnant 
women. In fact, if the infection develops in the first 
trimester, toxoplasmosis can lead to irreversible compli-
cations such as hydrocephaly, microcephaly, encephalitis 
and retinochoroiditis. Toxoplasma encephalitis can lead 
to brain calcification. Besides, vision loss, blindness and 
mental problems may also occur in this stage (Weiss and 
Dubey, 2009). Diagnosis of high risk people in the start of 
pregnancy should be performed using serological tests. 
Additionally, accurate treatment of pregnant women can 
decrease the risk of fetus infection up to 50% (Flori, 
2009). 
Indeed, accurate and rapid diagnosis of the infection in 
women who have been infected during gestation is of 
utmost importance in the outcome of the disease. 
Detection of specific antibodies using serological tests 
are one of the main diagnosis approaches. However, 
whole tachyzoites grown in mice serves as the antigen in 
most of the commercial kits, but they have cross reaction 







Figure 1. 2% agarose gel electrophoresis (PCR 
product). Lane 1: 100 bp DNA ladder marker; 




In recent years, attentions have focused on purified and 
recombinant surface molecules of tachyzoites and 
bradyzoites for developing a better serological test. Re-
searches have been conducted for developing recom-
binant form of these proteins for diagnosis purposes. 
Different antigens of tachyzoite and bradyzoite cover the 
surface of parasite. It is interesting that some of these 
antigens are specific to tachyzoite form including P30 
surface antigen 1 (SAG-1), P22 (SAG2) and P35, while 
other proteins present on both tachyzoite and bradyzoite 
such as P23 and P43 (SAG3) (Manger et al., 1998; 
Lekutis et al., 2001; Burg et al., 1988; Prince et al., 1990). 
The main goal of this study was to clone and express a 
gene encoding a P22 protein of T. gondii tachyzoite form. 
 
 




T. gondii tachyzoites (RH-strain) were harvested from the peritoneal 
fluid of infected mice. The fluid was then centrifuged and washed 
for three times using phosphate buffered saline. 
 
 
Genomic DNA extraction and PCR-reaction 
 
DNA lyses buffer were added to the compact pellet. Toxoplasma 
total genomic DNA was extracted as previously described (Zia-Ali et 
al., 2005). Primer designing were performed on the basis of nucle-
otide sequence of a P22 gene (accession number: AF249698). It 
should be mentioned that 5′ end of forward and reverse primers 
implicated with Sac1 and BamH1 restriction sites, respectively. The 
nucleotide sequences of primers were as following: 
 
P22 F 5`- GAG CTC ATG AGT TTC TCA AAG ACC AC 3`  
P22 R 5` - GGA TCC TTA CAC AAA CGT GAT CAA CAA-3` 
 
PCR reaction was set up in a 50 µL volume containing 1.25 U Taq 
DNA polymerase, 100 ng DNA, 1.5mM MgCl2, 0.1mM dNTP, 40 
pmol of forward and reverse primers , 1X PCR-buffer. PCR reaction  




was performed in theromocycler (Primus) through 35 cycles at 94°C 
for 30 sec (denaturation), 60°C for 30 sec (annealing) and 72°C for 
30 sec (extension) followed by last extension time of 10 min (72°C). 
 
 
Cloning and transformation 
 
PCR-product (560 bp) was purified using a low melting point (LMP) 
agarose gel as described previously (Gaastra and Jorgensen, 
1984) and ligated to PTZ57R plasmid via T/A cloning method. 
Competent cells were prepared according to Hanahan (1983) 
method. Reaction was spread on LB agar plate containing 50 
µg/mL ampicillin, 2 mM IPTG and 20 mg/ml X-gal. White colonies 
were selected as containing recombinant plasmids (Bothwell et al, 
1990), mass-cultured and plasmid extraction was performed using 
miniprep alkaline method (Feliciello and Chinali, 1993). 
Electrophoresis on 0.8% agarose gel was done (Boffey, 1984) and 
recombination was confirmed using restriction analysis using SacI 
and BamHI restriction enzymes.  
 
 
Sub-cloning and gene expression 
 
The P22 gene was subcloned into SacI and BamHI digested 
pET32a expression vector and transformed in E. coli (Bl21 DE3). 
Recombinant plasmids were selected and transformed into 
bacterial cell (Bl21 DE3). Bacterial colony containing recombinant 
plasmid was mass-cultured in YT medium (1.2% bacto trypton, 
2.4% yeast extract, 0.04% glycerol, 1% M9 salts) (M9 salts contain: 
6.4% Na2H2O4- 7H2O, 1.5% KH2PO4, 0.025% NaCl, 0.05% NH4Cl) 
(Kazemi et al, 2008). The culture was induced by 1 mM IPTG when 
OD600 = 0.5 to 0.7 and sampling were done before and after 
induction and analyzed by 12% SDS-PAGE (Smith, 1984). Western 
blot was done as described previously (Shewry and Fido, 1998). 
 
 
Purification of recombinant protein 
 
Purification was performed as described previously (Spiro et al., 
1997) with some modifications. Briefly, the induced bacterial cells 
were cultured in YT medium and pelleted using centrifugation at 
6500 rpm. The pellet was resuspended in 50 ml equilibration buffer 
(50 mM Tris, 0.5 M NaCl) containing a cocktail of protease inhibitors 
and frozen at -20°C. 
Pellet was sonicated (2X 30 sec), centrifuged (2000 rpm) for 15 
min and then resuspended in cold buffer containing 6 M urea. 
Incubation was performed on ice for an hour. Non soluble materials 
were decanted using centrifuge at12000 rpm for 20 min. 
The recombinant protein was purified by affinity chromatography, 
based on its N-terminal His6 tag using Ni-NTA His-bind resin. The 
cell lysate was applied to the column at a flow rate of 15 drops/min 
and allowed to bind. The bound protein was eluted with elution 







Primers were designed according to a gene encoding 
P22 (560bp). PCR reaction was done and the band were 





PCR-product   was    purified   using   low   melting   point  






Figure 2. The 1.5% agarose gel 
electrophoresis. Lane 1: 100 bp DNA ladder 







Figure 3. Gel electrophoresis of restriction 
analysis of recombinant plasmid. Lane 1: Xho 





agarose gel and cloned into pTZ57R T vector. Recom-
binant plasmids (pTZ P22) were then transformed into E. 
coli. After incubation at 37°C for 16 h, colony screening 
were done using alpha-complementation test. White colo-
nies (containing recombinant plasmids) were selected for 
further analysis. 
Recombinant plasmid was extracted and digested by 
SacI and BamHI (Figure 2) and released fragment (P22 
gene) was subcloned into SacI and BamHI digested 
pET32a expression vector. Recombination was confir-







Figure 4. SDS-PAGE analysis of bacterial cells. Lane 1: Induced 
bacterial cells containing PET32a; lane 2: Protein size marker; 
lane 3: Bacterial cells containing recombinant PET32a 4 h after 






XhoI enzyme has a restriction site on P22 gene at 
position 237 and a restriction site on pET32a at position 
158. If recombinant plasmid digested by XhoI, a 395 bp 
DNA fragment will released (Figure 3) and non-
recombinant plasmid will linear when digested by XhoI. 
Recombinant plasmid was purified, sequenced and 





The recombinant plasmid was transformed in to E. coli 
Bl21 (DE3) strain. Plasmid promoter was induced by 
IPTG. Before and after induction, bacterial samples were 
lysed and electrophoresed on 12% SDS-PAGE. Gel was 
stained by coomassie brilliant blue G250. Figure 4 shows 
protein band approximately 40 KDa (including Trx fusion 








Figure 5. Western blot analysis of recombinant P22 
by His tag monoclonal antibody. Lane 1: Bacterial cell 
lysates; lane 2: Bacterial cells containing PET32a; 





Purification of recombinant protein 
 
Bacteria lysate were sonicated and subjected to 
purification using affinity chromatography. SDS-PAGE 
was performed by two separate gel and the protein bands 
were transferred to nitrocellulose membrane using 
western blotting device. The membrane were exposed to 
UV cross linker and detected by His Tag mono clonal 





T. gondii is an intracellular coccidian parasite which can 
invade to almost every nucleated cells of intermediate 
host (Sibley, 1995). Delay in diagnosis of Toxoplasma 
infection in pregnant women who have been infected 
during the first trimester of gestation can lead to abortion. 
To date, serological tests are the main diagnosis 
methods for the detection of anti Toxoplasma antibody in 
serum samples (Aubert et al., 2000). However, whole 
tachyzoite proteins are used as an antigen in ELISA and 
IFA based tests. Since tachyzoites contains a wide 
variety of antigens may cross react by antiserum against 
other microorganisms. Additionally, presence of the non-
specific materials in the tachyzoite solution is one of the 
main drawbacks to these tests (Aubert et al., 2000). 
Therefore as mentioned before, specific antigens of 
tachyzoite form can open the way for more rapid and 
accurate diagnosis of toxoplasmosis. 
In this study, the recombinant P22 of T. gondii 
tachyzoite was prepared and the result showed that rP22 
can be used as an effective antigen for toxoplasmosis (un 
published data). Reports of Parmley et al (1992) revealed 
that all of the sera of patients with acute toxoplasmosis 
have been developed reaction with  rP22,  while,  sera  of  




chronic patients showed weaker reaction (Parmly et al., 
1992). Previous research regarding application of rP22 in 
ELISA test revealed that rP22 can introduce as an 






In this study, recombinant P22 was cloned and the 
screened tests revealed that rP22 can be use as a 
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